Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 1;19(6):244-247.
doi: 10.1002/cld.1218. eCollection 2022 Jun.

The clinical value of angiopoietin-2 in liver diseases

Maham Farshidpour  1 , Spencer Pace  2 , Michael L Volk  1
Affiliations
Review

The clinical value of angiopoietin-2 in liver diseases

Maham Farshidpour et al. Clin Liver Dis (Hoboken). .

Abstract

Content available: Audio Recording.

PubMed Disclaimer

Conflict of interest statement

Nothing to report.

Figures

FIGURE 1
FIGURE 1
Schematic showing the signal transduction with Tie2 and Ang1/2. Proposed model showing stimulatory effect (green arrows) and inhibitory effect (red arrows). Tie2 is expressed on the blood vessel and, when Ang1 binding causes a stimulatory effect, thus downstream signal transduction. Ang2 has an inhibitory effect on Ang1. Ang1, Angiopoietin 1; Ang2, Angiopoietin 2; VEGF, vascular endothelial Growth factor; NF‐κβ, nuclear factor kappa‐light‐chain‐enhancer of activated B cells; PI3K/AKT, Phosphatidylinositol‐3‐Kinase/Protein kinase B
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Yamashita S, Kudo A, Kawakami H, Okada Y. Mechanisms of angiogenic suppression in uteri exposed to diethylstilbestrol neonatally in the mouse. Biol Reprod. 2013;88:116. - PubMed
    1. Akwii RG, Sajib MS, Zahra FT, Mikelis CM. Role of angiopoietin‐2 in vascular physiology and pathophysiology. Cells. 2019;8:471. - PMC - PubMed
    1. Elpek GO. Angiogenesis and liver fibrosis. World J Hepatol. 2015;7:377–91. - PMC - PubMed
    1. Lefere S, Van de Velde F, Hoorens A, Raevens S, Van Campenhout S, Vandierendonck A, et al. Angiopoietin‐2 promotes pathological angiogenesis and is a therapeutic target in murine nonalcoholic fatty liver disease. Hepatology. 2019;69:1087–104. - PubMed
    1. Olsson A‐K, Dimberg A, Kreuger J,Claesson‐Welsh L. VEGF receptor signalling ‐ in control of vascular function. Nat Rev Mol Cell Biol. 2006;7:359–71. - PubMed